507207992	507207992	CD	B-NP	O
|	|	NN	I-NP	O
OAYH	OAYH	NN	I-NP	O
|	|	NN	I-NP	O
59482838	59482838	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3346976	3346976	CD	B-NP	O
|	|	CC	I-NP	O
9/26/2005	9/26/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Diastolic	Diastolic	JJ	I-NP	I-protein
dysfunction	dysfunction	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/24/2005	2/24/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
12/10/2005	12/10/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
REHLANDER	REHLANDER	NNP	B-NP	O
,	,	,	O	O
MITCHELL	MITCHELL	NNP	B-NP	O
992-84-99-1	992-84-99-1	CD	I-NP	O
Sun	Sun	NNP	I-NP	O
I	I	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
9/3/05	9/3/05	CD	B-NP	O
AT	AT	NN	I-NP	O
06	06	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SUK	SUK	NNP	B-NP	O
,	,	,	O	O
MERRILL	MERRILL	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/3/05	9/3/05	CD	B-NP	O
by	by	IN	B-PP	O
SPECIALE	SPECIALE	NNP	B-NP	O
,	,	,	O	O
STANLEY	STANLEY	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
92519934	92519934	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/29/05	11/29/05	CD	B-NP	O
by	by	IN	B-PP	O
BRINGHURST	BRINGHURST	NNP	B-NP	O
,	,	,	O	O
BASIL	BASIL	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NN	B-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
64541940	64541940	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/23/05	8/23/05	CD	B-NP	O
by	by	IN	B-PP	O
BRAUMAN	BRAUMAN	NNP	B-NP	O
,	,	,	O	O
DEVON	DEVON	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
07389371	07389371	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
ZOCOR	ZOCOR	NN	B-NP	B-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
80	80	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

NORVASC	NORVASC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

LANTUS	LANTUS	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QD	QD	NNP	I-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6-12	6-12	NN	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
June	June	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Other	Other	NNP	I-NP	O
:	:	:	O	O
meals	meal	NNS	B-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
NPO	NPO	NN	B-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
,	,	,	O	O
give	give	VB	B-VP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
MAXZIDE	MAXZIDE	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
TRIAMTERENE	TRIAMTERENE	NN	I-NP	B-protein
75MG/HYDROCHLOROTHIAZID	75MG/HYDROCHLOROTHIAZID	NN	I-NP	I-protein
...	...	:	O	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/3/05	9/3/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
TRIAMTERENE	TRIAMTERENE	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
TRIAMTERENE	TRIAMTERENE	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
TRIAMTERENE	TRIAMTERENE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
METFORMIN	METFORMIN	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Fertal	Fertal	NNP	I-NP	O
-	-	:	O	O
within	within	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Diastolic	Diastolic	NNP	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
Hypertension	Hypertension	NNP	I-NP	O
,	,	,	O	O
DM	DM	NNP	B-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Diuresis	Diuresis	NNP	I-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
lasix	lasix	CD	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
LE	LE	NN	B-NP	O
edema	edema	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
42	42	CD	B-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
CHF	CHF	NN	I-NP	B-protein
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
yr	yr	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
EF	EF	NN	I-NP	O
not	not	RB	B-VP	O
known	know	VBN	I-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
increasing	increase	VBG	B-VP	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
25	25	CD	I-NP	O
lb	lb	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
DOE	DOE	NNP	I-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
LE	LE	NN	B-NP	B-protein
edema	edema	NN	I-NP	I-protein
x	x	NN	I-NP	I-protein
last	last	JJ	B-NP	I-protein
several	several	JJ	I-NP	I-protein
weeks	week	NNS	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

denies	deny	NNS	B-NP	O
f/c	f/c	NN	I-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
n/v/d	n/v/d	NN	B-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
CP	CP	NN	B-NP	B-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
medical	medical	JJ	B-NP	O
compliance	compliance	NN	I-NP	O
and	and	CC	O	O
follows	follow	VBZ	B-VP	O
a	a	DT	B-NP	O
low-salt	low-salt	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
recent	recent	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

does	do	VBZ	O	O
reports	report	NNS	B-NP	O
chronic	chronic	JJ	B-NP	O
,	,	,	I-NP	O
intermittent	intermittent	JJ	I-NP	O
palpitations	palpitation	NNS	I-NP	O
-LRB-	-LRB-	NNP	B-NP	O
first	first	RB	B-ADVP	O
noticed	notice	VBD	B-VP	O
several	several	JJ	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
now	now	RB	B-ADVP	O
more	more	RBR	B-NP	O
frequent	frequent	JJ	I-NP	O
+	+	SYM	I-NP	O
lengthy	lengthy	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
.	.	.	O	O

was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
P	P	NN	B-NP	B-protein
88	88	CD	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	O
157/79	157/79	CD	I-NP	O
,	,	,	O	O
sat	sit	VBD	B-VP	O
89	89	CD	B-NP	O
%	%	NN	I-NP	O
Ra	Ra	NN	I-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
3L	3L	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
JVD	JVD	NN	B-NP	B-protein
,	,	,	O	O
bibasilar	bibasilar	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
+	+	SYM	O	O
LE	LE	NN	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
labs	lab	NNS	I-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
BNP	BNP	NN	B-NP	B-protein
533	533	CD	I-NP	I-protein
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	B-protein
markers	marker	NNS	I-NP	I-protein
negative	negative	JJ	B-NP	I-protein
x	x	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
,	,	,	O	O
WBC	WBC	NNP	B-NP	B-cell_line
14.6	14.6	CD	I-NP	I-cell_line
,	,	,	O	O
UA	UA	NNP	B-NP	O
+	+	SYM	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
LAE	LAE	NN	B-NP	O
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
,	,	,	O	O
STD	STD	NN	B-NP	O
+	+	SYM	B-NP	O
TWI	TWI	NN	I-NP	O
in	in	IN	B-PP	O
lateral	lateral	JJ	B-NP	O
leads	lead	NNS	I-NP	O
-LRB-	-LRB-	IN	B-PP	O
no	no	DT	B-NP	O
comparison	comparison	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
CXR	CXR	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	SYM	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
small	small	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-VP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
NTGN	NTGN	NN	B-NP	B-protein
,	,	,	O	O
lasix	lasix	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
levaquin	levaquin	NN	B-NP	O
.	.	.	O	O

PMHx	PMHx	NN	B-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	B-protein
-LRB-	-LRB-	:	O	O
no	no	DT	B-NP	O
ECHO	ECHO	NN	I-NP	B-protein
on	on	IN	B-PP	O
file	file	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
retinopathy	retinopathy	NN	B-NP	O
,	,	,	O	O
nephropathy	nephropathy	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
MEDS	MEDS	NNP	I-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
norvasc	norvasc	NN	B-NP	O
,	,	,	O	O
lasix	lasix	NN	B-NP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
,	,	,	O	O
lantus	lantus	NN	B-NP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
,	,	,	O	O
maxzide	maxzide	NN	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	O
SOC	SOC	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
ppd	ppd	NN	I-NP	O
x	x	SYM	B-NP	O
10	10	CD	B-NP	O
yrs	yr	NNS	I-NP	O
;	;	:	O	O
former	former	JJ	B-NP	O
10	10	CD	I-NP	O
beers	beer	NNS	I-NP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	B-protein
0	0	CD	B-NP	I-protein
quit	quit	NN	I-NP	I-protein
3	3	CD	B-NP	I-protein
yrs	yr	NNS	I-NP	I-protein
ago	ago	RB	B-ADVP	O
;	;	:	O	O
no	no	DT	B-NP	O
drugs	drug	NNS	I-NP	O
;	;	:	O	O
lives	live	VBZ	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	O	O
3	3	CD	B-NP	O
children	child	NNS	I-NP	O
FAMHx	FAMHx	NN	I-NP	O
:	:	:	O	O
FHx	FHx	NN	B-NP	O
DM	DM	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
family	family	NN	I-NP	O
hx	hx	NN	I-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
sudden	sudden	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
death	death	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
97.6	97.6	CD	I-NP	O
P	P	NN	I-NP	O
88	88	CD	B-NP	O
BP	BP	NN	I-NP	O
157/79	157/79	CD	B-NP	O
NAD	NAD	NN	I-NP	O
;	;	:	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
speak	speak	VB	I-VP	O
in	in	IN	B-PP	O
sentences	sentence	NNS	B-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
thyromegaly	thyromegaly	RB	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruit	bruit	NN	I-NP	O
;	;	:	O	O
decreased	decrease	VBN	B-NP	O
BS	BS	NN	I-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
crackles	crackle	NNS	I-NP	O
1/2	1/2	CD	B-NP	O
way	way	NN	I-NP	O
up	up	RB	B-ADVP	O
;	;	:	O	O
JVP	JVP	NN	B-NP	B-protein
to	to	TO	B-VP	O
earlobe	earlobe	VB	I-VP	O
sitting	sit	VBG	I-VP	O
upright	upright	NN	B-NP	O
;	;	:	O	O
RV	RV	NN	B-NP	O
heave	heave	NN	I-NP	O
;	;	:	O	O
RRR	RRR	NN	B-NP	O
S1S2	S1S2	NN	I-NP	O
S3S4	S3S4	NN	I-NP	O
;	;	:	O	O
abd	abd	NN	B-NP	O
soft	soft	JJ	I-NP	O
NT	NT	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
HSM	HSM	NN	I-NP	B-protein
;	;	:	O	O
ext	ext	NN	B-NP	O
3	3	CD	I-NP	O
+	+	SYM	I-NP	O
pitting	pitting	NN	I-NP	O
edema	edema	NN	I-NP	O
;	;	:	O	O
warm	warm	JJ	B-NP	O
w/o	w/o	NN	I-NP	O
clubbing	clubbing	NN	I-NP	O
;	;	:	O	O
alert	alert	NN	B-NP	O
+	+	SYM	B-NP	O
oriented	orient	VBN	B-VP	O
-	-	HYPH	B-NP	O
grossly	grossly	RB	I-NP	O
non-focal	non-focal	JJ	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
K	K	NN	B-NP	O
4.2	4.2	NN	I-NP	O
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
0.9	0.9	CD	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	B-cell_line
14.6	14.6	CD	I-NP	I-cell_line
,	,	,	O	O
Hct	Hct	NN	B-NP	B-protein
37.7	37.7	CD	I-NP	I-protein
,	,	,	O	O
Plt	Plt	NNP	B-NP	O
277	277	CD	I-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-cell_line
199	199	CD	I-NP	I-cell_line
,	,	,	O	O
CKMB	CKMB	NN	B-NP	B-protein
5.3	5.3	CD	I-NP	I-protein
,	,	,	O	O
Tn	Tn	NN	B-NP	B-protein
I	I	NN	I-NP	O
<	<	SYM	O	O
assay	assay	NN	B-NP	O
,	,	,	O	O
BNP	BNP	NN	B-NP	B-protein
533	533	CD	I-NP	I-protein
UA	UA	NN	I-NP	I-protein
3	3	CD	B-NP	I-protein
+	+	SYM	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
WBC	WBC	NN	B-NP	B-protein
,	,	,	O	O
RBC	RBC	NN	B-NP	O
2-5	2-5	CD	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	O
LE	LE	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
EKG	EKG	NNP	I-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	O
@	@	NN	I-NP	O
79	79	CD	B-NP	O
bmp	bmp	NN	I-NP	O
;	;	:	O	O
nl	nl	NN	B-NP	O
axis	axis	NN	I-NP	O
;	;	:	O	O
LAE	LAE	NN	B-NP	O
;	;	:	O	O
LVH	LVH	NN	B-NP	O
;	;	:	O	O
TWI	TWI	NN	B-NP	O
I	I	NN	I-NP	O
,	,	,	O	O
AVL	AVL	NN	B-NP	B-protein
,	,	,	O	O
V5-V6	V5-V6	NN	B-NP	O
;	;	:	O	O
STdep	STdep	NN	B-NP	O
I	I	NN	I-NP	O
,	,	,	O	O
AVL	AVL	NN	B-NP	B-protein
,	,	,	O	O
V5-V	V5-V	NN	B-NP	O
^	^	NN	I-NP	O
~	~	NN	I-NP	O
0.5	0.5	CD	I-NP	O
mm	mm	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
old	old	JJ	I-NP	O
for	for	IN	B-PP	O
comparison	comparison	NN	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
CXR	CXR	NN	I-NP	O
:	:	:	O	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
small	small	JJ	B-NP	O
B	B	NN	I-NP	O
effusions	effusion	NNS	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
42	42	CD	B-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
DM	DM	NN	B-NP	O
,	,	,	O	O
htn	htn	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
forger	forger	NN	B-NP	O
cigs	cig	NNS	I-NP	O
p/w	p/w	VBP	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
pump	pump	VB	B-VP	O
:	:	:	O	O
*	*	SYM	B-NP	O
CHF/HTN	CHF/HTN	NN	I-NP	O
*	*	SYM	B-NP	O
Possible	Possible	JJ	B-NP	O
etiologies	etiology	NNS	I-NP	O
include	include	VBP	B-VP	O
a	a	DT	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
ischemia	ischemia	NN	I-NP	O
-	-	HYPH	B-PP	O
ROMI	ROMI	NN	B-NP	O
complete	complete	JJ	B-ADJP	O
,	,	,	O	O
10/27	10/27	CD	B-NP	O
ECHO	ECHO	NN	I-NP	O
shows	show	VBZ	B-VP	O
preserved	preserve	VBN	B-NP	O
EF	EF	NN	I-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
PHTN	PHTN	NN	B-NP	B-protein
,	,	,	O	O
ETT	ETT	NNP	B-NP	O
MIBI	MIBI	NNP	I-NP	O
planned	plan	VBD	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
b	b	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
c	c	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
thyroid	thyroid	NN	I-NP	O
-	-	HYPH	O	O
TSH	TSH	NN	B-NP	B-DNA
0.6	0.6	CD	I-NP	I-DNA
.	.	.	O	O

d	d	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
infiltrative	infiltrative	JJ	I-NP	O
-	-	HYPH	I-NP	O
iron	iron	NN	I-NP	O
studies	study	NNS	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
hemochromatosis	hemochromatosis	NN	B-NP	O
.	.	.	O	O

f	f	NN	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
EtOH	EtOH	NN	I-NP	B-protein
g	g	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
other	other	JJ	I-NP	O
misc	misc	NN	I-NP	O
.	.	.	O	O

Trigger	Trigger	NN	B-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
arrythmia	arrythmia	NN	B-NP	O
,	,	,	O	O
UTI	UTI	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
bblocker	bblocker	NN	B-NP	O
,	,	,	O	O
acei	acei	NN	B-NP	O
,	,	,	O	O
hctz	hctz	NN	B-NP	O
,	,	,	O	O
lasix	lasix	CD	B-NP	O
40	40	CD	I-NP	O
IV	IV	CD	I-NP	O
bid	bid	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
goal	goal	NN	B-NP	B-protein
-1	-1	CD	I-NP	I-protein
/	/	SYM	O	O
5	5	CD	B-NP	O
to	to	TO	B-PP	O
2L	2L	NN	B-NP	B-protein
.	.	.	O	O

Diuresed	Diurese	VBN	B-VP	O
nicely	nicely	RB	B-ADVP	O
.	.	.	O	O

Changed	Change	VBN	B-VP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
PO	PO	NN	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

Check	Check	VB	B-VP	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
,	,	,	O	O
I/O	I/O	NN	B-NP	B-protein
,	,	,	O	O
bid	bid	NN	B-NP	O
lytes	lyte	NNS	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
HTN	HTN	NN	I-NP	O
discovered	discover	VBN	B-VP	O
on	on	IN	B-PP	O
ECHO	ECHO	NN	B-NP	B-protein
may	may	MD	B-VP	O
relate	relate	VB	I-VP	O
to	to	TO	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
reevaluated	reevaluate	VBN	I-VP	O
once	once	RB	B-ADJP	O
pt	pt	JJ	I-ADJP	O
.	.	.	O	O

has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
diuresed	diurese	VBN	I-VP	O
.	.	.	O	O

Would	Would	MD	B-VP	O
also	also	RB	I-VP	O
favor	favor	VB	I-VP	O
evaluation	evaluation	NN	B-NP	O
for	for	IN	B-PP	O
OSA	OSA	NN	B-NP	O
.	.	.	O	O

ischemia	ischemia	SYM	O	O
:	:	:	O	O
*	*	SYM	B-NP	O
no	no	DT	B-NP	O
hx	hx	NN	I-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
RF	RF	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
+	+	JJ	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
*	*	SYM	O	O
ROMIcomplete	ROMIcomplete	NN	B-NP	O
,	,	,	O	O
tele	tele	NN	B-NP	O
,	,	,	O	O
lytes	lyte	NNS	B-NP	O
.	.	.	O	O

10/27	10/27	CD	B-NP	O
ECHO	ECHO	NN	I-NP	O
w/o	w/o	NN	I-NP	O
wma	wma	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
changes	change	NNS	I-NP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
LVG	LVG	NN	B-NP	B-protein
.	.	.	O	O

Rx	Rx	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-VP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
bblocker	bblocker	NN	B-NP	O
,	,	,	O	O
acei	acei	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
.	.	.	O	O

Plan	Plan	NNP	B-NP	O
for	for	IN	B-PP	O
ETT	ETT	NNP	B-NP	O
MIBI	MIBI	NNP	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

rhythm	rhythm	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
NSR	NSR	NN	I-NP	B-protein
but	but	CC	O	O
subjective	subjective	JJ	B-NP	O
palpitations	palpitation	NNS	I-NP	O
*	*	SYM	O	O
Tele	Tele	NNP	B-NP	O
,	,	,	O	O
lytes	lyte	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
e/o	e/o	NN	I-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
.	.	.	O	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	B-cell_type
DOE	DOE	NN	I-NP	I-cell_type
*	*	SYM	O	I-cell_type
Likely	Likely	RB	B-ADJP	O
related	relate	VBN	I-ADJP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

Wean	Wean	JJ	B-ADJP	O
off	off	IN	B-PP	O
O2	O2	NN	B-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
-LRB-	-LRB-	SYM	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	I-NP	O
diuresis	diuresis	NN	I-NP	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
-	-	HYPH	B-ADVP	O
came	come	VBD	B-VP	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
O2	O2	NN	B-NP	B-protein
and	and	CC	B-PP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
Cardiac/ADA	Cardiac/ADA	NN	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
bowel	bowel	NN	B-NP	O
reg	reg	NN	I-NP	O
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
Cr	Cr	NN	I-NP	O
wnl	wnl	NN	I-NP	O
*	*	SYM	B-NP	O
Bid	Bid	NN	I-NP	O
lytes	lyte	NNS	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
aggressive	aggressive	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
*	*	SYM	B-NP	B-cell_type
DM	DM	NN	I-NP	I-cell_type
*	*	SYM	B-NP	I-cell_type
Lantus	Lantus	NNP	I-NP	O
+	+	SYM	I-NP	O
lispro	lispro	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
meals	meal	NNS	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
UTI	UTI	NN	I-NP	O
by	by	IN	B-PP	O
UA	UA	NN	B-NP	O
*	*	SYM	O	O
CHeck	CHeck	NN	B-NP	O
Cx	Cx	NN	I-NP	O
.	.	.	O	O

continue	continue	VB	B-VP	O
levo	levo	NN	B-NP	B-protein
x	x	SYM	O	I-protein
3	3	CD	B-NP	I-protein
days	day	NNS	I-NP	I-protein
-LRB-	-LRB-	NNP	B-NP	I-protein
started	start	VBD	B-VP	O
8/3	8/3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PROPH	PROPH	NN	I-NP	O
:	:	:	O	O
lovenox	lovenox	NN	B-NP	O
CODE	CODE	NN	I-NP	O
:	:	:	O	O
full	full	JJ	B-NP	O
ADDITIONAL	ADDITIONAL	JJ	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Tourtellotte	Tourtellotte	NNP	I-NP	O
within	within	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Daily	Daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
record	record	VB	B-VP	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
weight	weight	NN	B-NP	O
up	up	RB	B-ADVP	O
by	by	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
3	3	CD	I-NP	O
lbs	lb	NNS	I-NP	O
,	,	,	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
a	a	DT	B-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
,	,	,	O	O
repeat	repeat	NN	B-NP	O
Echo	Echo	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
evaluation	evaluation	NN	B-NP	O
for	for	IN	B-PP	O
causes	cause	NNS	B-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
FOGELMAN	FOGELMAN	NN	B-NP	O
,	,	,	O	O
REY	REY	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TN43	TN43	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
9/3/05	9/3/05	CD	I-NP	O
@	@	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
47	47	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

